UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.253-264

2019

Link zum Volltext

Verfügbarkeit prüfen

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load

PLoS computational biology, 2023-01, Vol.19 (1), p.e1010756-e1010756

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with D-dimer levels in HIV-infected individuals

PloS one, 2014-03, Vol.9 (3), p.e90978-e90978

2014

Link zum Volltext

Verfügbarkeit prüfen

Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina

HIV medicine, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

PloS one, 2015-12, Vol.10 (12), p.e0145380-e0145380

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

The lancet respiratory medicine, 2019-11, Vol.7 (11), p.951-963

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies

PloS one, 2014-07, Vol.9 (7), p.e101785

2014

Link zum Volltext

Verfügbarkeit prüfen

Monkeypox: description of two cases under follow-up in Buenos Aires

Medicina, 2022-10, Vol.82 (5), p.774

2022

Link zum Volltext

Verfügbarkeit prüfen

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

The Lancet infectious diseases, 2017-12, Vol.17 (12), p.1255-1265

2017

Link zum Volltext

Verfügbarkeit prüfen

Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus

Journal of Virology, 2013-07, Vol.87 (14), p.8064-8074

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2317-2324

2020

Link zum Volltext

Verfügbarkeit prüfen

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy–Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

The Journal of infectious diseases, 2019-09, Vol.220 (8), p.1325-1334

2019

Link zum Volltext

Verfügbarkeit prüfen

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Journal of hepatology, 2013-08, Vol.59 (2), p.213-220

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3

PloS one, 2017-05, Vol.12 (5), p.e0176009-e0176009

2017

Link zum Volltext

Verfügbarkeit prüfen

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

BMC infectious diseases, 2018-04, Vol.18 (1), p.191-191, Article 191

2018

Link zum Volltext

Verfügbarkeit prüfen

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

HIV research & clinical practice, 2021-12, Vol.22 (6), p.160-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

The lancet HIV, 2015-02, Vol.2 (2), p.e42-e51

2015

Link zum Volltext

Verfügbarkeit prüfen

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

HIV research & clinical practice, 2022-07, Vol.23 (1), p.37-46

2022

Link zum Volltext

Verfügbarkeit prüfen

When should antiretroviral therapy for HIV be started?

BMJ (British Medical Journal), 2007-01, Vol.334 (7584), p.76-78

International edition, 2007

Link zum Volltext

Verfügbarkeit prüfen

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D 2 EFT

HIV research & clinical practice, 2022-12, Vol.23 (1), p.37-46

2022

Link zum Volltext

Verfügbarkeit prüfen

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

The European respiratory journal, 2014-01, Vol.43 (1), p.166-177

2014

Link zum Volltext

Verfügbarkeit prüfen

Repeat pregnancy in women with HIV infection in Latin America and the Caribbean

AIDS care, 2015-10, Vol.27 (10), p.1289-1297

2015

Link zum Volltext

Verfügbarkeit prüfen

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

Pediatrics (Evanston), 2007-03, Vol.119 (3), p.e694

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(137)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load

Factors associated with D-dimer levels in HIV-infected individuals

Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies

Monkeypox: description of two cases under follow-up in Buenos Aires

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus

Prevalence and outcomes of pregnancies in women with HIV over a 20-year period

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy–Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

When should antiretroviral therapy for HIV be started?

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D 2 EFT

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

Repeat pregnancy in women with HIV infection in Latin America and the Caribbean

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

Suchergebnisse filtern